Tripeptide Arg-Gly-Asp (RGD) modifies the molecular mechanical properties of the non-muscle myosin IIA in human bone marrow-derived myofibroblasts seeded in a collagen scaffold

Autoři: Yves Lecarpentier aff001;  Vincent Kindler aff002;  Marie-Luce Bochaton-Piallat aff003;  Antonija Sakic aff003;  Victor Claes aff004;  Jean-Louis Hébert aff005;  Alexandre Vallée aff006;  Olivier Schussler aff008
Působiště autorů: Centre de Recherche Clinique, Grand Hôpital de l’Est Francilien, Meaux, France aff001;  Department of Specialties in Medicine, Hematology Service, Geneva University Hospital, Switzerland Faculty of Medicine, Geneva, Switzerland aff002;  Department of Pathology and Immunology, Centre Médical Universitaire Geneva, Faculty of Medicine, Geneva, Switzerland aff003;  Department of Pharmaceutical Sciences, University of Antwerp, Wilrijk, Belgium aff004;  Institut de Cardiologie, Hôpital de la Pitié-Salpétrière, Paris, France aff005;  Paris-Descartes University, Diagnosis and Therapeutic Center, Hypertension and Cardiovascular Prevention Unit, Hôtel-Dieu Hospital, Paris, France aff006;  DRCI (Délégation à la Recherche Clinique et Industrielle) Hôpital Foch, Suresnes, France aff007;  Department of Cardiovascular Surgery, Research Laboratory, Geneva University Hospitals, Geneva, Switzerland aff008
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article
doi: 10.1371/journal.pone.0222683


Mesenchymal stem cells (MSCs) were obtained from human bone marrow and amplified in cultures supplemented with human platelet lysate in order to generate myofibroblasts. When MSCs were seeded in solid collagen scaffolds, they differentiated into myofibroblasts that were observed to strongly bind to the substrate, forming a 3D cell scaffold network that developed tension and shortening after KCl stimulation. Moreover, MSC-laden scaffolds recapitulated the Frank-Starling mechanism so that active tension increased in response to increases in the initial length of the contractile system. This constituted a bioengineering tissue that exhibited the contractile properties observed in both striated and smooth muscles. By using the A. F. Huxley formalism, we determined the myosin crossbridge (CB) kinetics of attachment (f1) and detachment (g1 and g2), maximum myosin ATPase activity, molar myosin concentration, unitary CB force and maximum CB efficiency. CB kinetics were dramatically slow, characterizing the non-muscle myosin type IIA (NMMIIA) present in myofibroblasts. When MSCs were seeded in solid collagen scaffolds functionalized with Arg-Gly-Asp (RGD), contractility increased and CB kinetics were modified, whereas the unitary NMMIIA-CB force and maximum CB efficiency did not change. In conclusion, we provided a non-muscle bioengineering tissue whose molecular mechanical characteristics of NMMIIA were very close to those of a non-muscle contractile tissue such as the human placenta.

Klíčová slova:

Adenosine triphosphatase – Collagens – Fibroblasts – Mechanical properties – Mesenchymal stem cells – Muscle contraction – Myosins – Mechanical tension


1. Lecarpentier Y, Schussler O, Sakic A, Rincon-Garriz JM, Soulie P, Bochaton-Piallat ML, et al. Human Bone Marrow Contains Mesenchymal Stromal Stem Cells That Differentiate In Vitro into Contractile Myofibroblasts Controlling T Lymphocyte Proliferation. Stem Cells Int. 2018;2018:6134787. Epub 2018/06/02. doi: 10.1155/2018/6134787 29853916

2. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971;27(5):549–50. Epub 1971/05/15. doi: 10.1007/bf02147594 5132594.

3. Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G. Granulation tissue as a contractile organ. A study of structure and function. The Journal of experimental medicine. 1972;135(4):719–34. Epub 1972/04/01. doi: 10.1084/jem.135.4.719 4336123.

4. Feller AC, Schneider H, Schmidt D, Parwaresch MR. Myofibroblast as a major cellular constituent of villous stroma in human placenta. Placenta. 1985;6(5):405–15. Epub 1985/09/01. doi: 10.1016/s0143-4004(85)80017-5 2866507.

5. Hinz B. The role of myofibroblasts in wound healing. Current research in translational medicine. 2016;64(4):171–7. Epub 2016/12/13. doi: 10.1016/j.retram.2016.09.003 27939455.

6. Hinz B. The myofibroblast: paradigm for a mechanically active cell. Journal of biomechanics. 2010;43(1):146–55. Epub 2009/10/06. doi: 10.1016/j.jbiomech.2009.09.020 19800625.

7. Lecarpentier Y, Schussler O, Claes V, Vallée A. The Myofibroblast: TGFβ-1, A Conductor which Plays a Key Role in Fibrosis by Regulating the Balance between PPARγ and the Canonical WNT Pathway Nuclear Receptor Research 2017;4. doi: 10.11131/2017/101299

8. Barbosa FL, Chaurasia SS, Cutler A, Asosingh K, Kaur H, de Medeiros FW, et al. Corneal myofibroblast generation from bone marrow-derived cells. Experimental eye research. 2010;91(1):92–6. Epub 2010/04/27. doi: 10.1016/j.exer.2010.04.007 20417632

9. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. The Journal of cell biology. 1998;142(3):873–81. Epub 1998/08/12. doi: 10.1083/jcb.142.3.873 9700173

10. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. The Journal of cell biology. 1993;122(1):103–11. Epub 1993/07/01. doi: 10.1083/jcb.122.1.103 8314838

11. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. Journal of cellular physiology. 2005;205(2):228–36. Epub 2005/05/12. doi: 10.1002/jcp.20391 15887229.

12. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature reviews Molecular cell biology. 2002;3(5):349–63. Epub 2002/05/04. doi: 10.1038/nrm809 11988769.

13. Goffin JM, Pittet P, Csucs G, Lussi JW, Meister JJ, Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. The Journal of cell biology. 2006;172(2):259–68. Epub 2006/01/13. doi: 10.1083/jcb.200506179 16401722

14. Lecarpentier E, Claes V, Timbely O, Hebert JL, Arsalane A, Moumen A, et al. Role of both actin-myosin cross bridges and NO-cGMP pathway modulators in the contraction and relaxation of human placental stem villi. Placenta. 2013;34(12):1163–9. Epub 2013/11/05. doi: 10.1016/j.placenta.2013.10.007 24183754.

15. Frank O. Zur Dynamik des Herzmuskels. Z Biol. 1895;32:273–7

16. Starling EH. The Arris and Gale Lectures on some points in the pathology of heart disease. Lecture I. The compensating mechanism of the heart. Lancet. 1897;1:569–72.

17. Hill AV. The heat of shortening and the dynamic constants of muscle. Proc R Soc Lond Biol Sci. 1938;126:136–95.

18. Huxley AF. Muscle structure and theories of contraction. Prog Biophys Biophys Chem. 1957;7:255–318. 13485191.

19. Lecarpentier Y, Claes V, Lecarpentier E, Guerin C, Hebert JL, Arsalane A, et al. Ultraslow myosin molecular motors of placental contractile stem villi in humans. PloS one. 2014;9(9):e108814. Epub 2014/10/01. doi: 10.1371/journal.pone.0108814 25268142

20. Matsumura S, Sakurai K, Shinomiya T, Fujitani N, Key K, Ohashi M. Biochemical and immunohistochemical characterization of the isoforms of myosin and actin in human placenta. Placenta. 2011;32(5):347–55. Epub 2011/03/23. doi: 10.1016/j.placenta.2011.02.008 21420731.

21. Conti MA, Adelstein RS. Nonmuscle myosin II moves in new directions. Journal of cell science. 2008;121(Pt 1):11–8. Epub 2007/12/22. doi: 10.1242/jcs.007112 18096687.

22. Kovacs M, Wang F, Hu A, Zhang Y, Sellers JR. Functional divergence of human cytoplasmic myosin II: kinetic characterization of the non-muscle IIA isoform. The Journal of biological chemistry. 2003;278(40):38132–40. Epub 2003/07/09. doi: 10.1074/jbc.M305453200 12847096.

23. Schussler O, Coirault C, Louis-Tisserand M, Al-Chare W, Oliviero P, Menard C, et al. Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nature clinical practice Cardiovascular medicine. 2009;6(3):240–9. doi: 10.1038/ncpcardio1451 19234502.

24. Beer JH, Springer KT, Coller BS. Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood. 1992;79(1):117–28. Epub 1992/01/01. 1728303.

25. Craig WS, Cheng S, Mullen DG, Blevitt J, Pierschbacher MD. Concept and progress in the development of RGD-containing peptide pharmaceuticals. Biopolymers. 1995;37(2):157–75. Epub 1995/01/01. doi: 10.1002/bip.360370209 7534489.

26. Myles JL, Burgess BT, Dickinson RB. Modification of the adhesive properties of collagen by covalent grafting with RGD peptides. Journal of biomaterials science Polymer edition. 2000;11(1):69–86. Epub 2000/02/19. doi: 10.1163/156856200743508 10680609.

27. Veech RL, Lawson JW, Cornell NW, Krebs HA. Cytosolic phosphorylation potential. The Journal of biological chemistry. 1979;254(14):6538–47. 36399.

28. Sheterline P, Clayton J., Sparrow J.C. Protein Profile. 3rd edition ed. London: Academic Press; 1996.

29. Huxley AF, Simmons RM. Mechanical properties of the cross-bridges of frog striated muscle. The Journal of physiology. 1971;218(1):59P–60P. 5130636.

30. Rayment I, Holden HM, Whittaker M, Yohn CB, Lorenz M, Holmes KC, et al. Structure of the actin-myosin complex and its implications for muscle contraction. Science. 1993;261(5117):58–65. doi: 10.1126/science.8316858 8316858.

31. Lecarpentier Y, Blanc FX, Quillard J, Hebert JL, Krokidis X, Coirault C. Statistical mechanics of myosin molecular motors in skeletal muscles. Journal of theoretical biology. 2005;235(3):381–92. doi: 10.1016/j.jtbi.2005.01.018 15882700.

32. Lecarpentier Y, Claes V, Krokidis X, A Vallée A. Comparative Statistical Mechanics of Muscle and Non-Muscle Contractile Systems: Stationary States of Near-Equilibrium Systems in A Linear Regime. Entropy Journal 2017;19(10):558.

33. Krantz EK, Parker JC. Contractile properties of the smooth muscle in the human placenta. Clin Obstet Gynecol 1963;6:26–38.

34. Farley AE, Graham CH, Smith GN. Contractile properties of human placental anchoring villi. American journal of physiology Regulatory, integrative and comparative physiology. 2004;287(3):R680–5. Epub 2004/05/15. doi: 10.1152/ajpregu.00222.2004 15142834.

35. Starling EH. The Linacre Lecture on the Law of the Heart. Longmans, Green & Co, London. 1918.

36. Gordon AM, Huxley AF, Julian FJ. The variation in isometric tension with sarcomere length in vertebrate muscle fibres. The Journal of physiology. 1966;184(1):170–92. doi: 10.1113/jphysiol.1966.sp007909 5921536.

37. Hill AV. Thermodynamics of muscle. Nature. 1951;167(4245):377–80. doi: 10.1038/167377a0 14826751.

38. Barany M. ATPase activity of myosin correlated with speed of muscle shortening. The Journal of general physiology. 1967;50(6):Suppl:197–218. doi: 10.1085/jgp.50.6.197 4227924.

39. Van De Water L, Varney S, Tomasek JJ. Mechanoregulation of the Myofibroblast in Wound Contraction, Scarring, and Fibrosis: Opportunities for New Therapeutic Intervention. Advances in wound care. 2013;2(4):122–41. Epub 2014/02/15. doi: 10.1089/wound.2012.0393 24527336

40. D’Souza SE, Ginsberg MH, Plow EF. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends in biochemical sciences. 1991;16(7):246–50. Epub 1991/07/01. doi: 10.1016/0968-0004(91)90096-e 1926332.

41. Kapp TG, Rechenmacher F, Neubauer S, Maltsev OV, Cavalcanti-Adam EA, Zarka R, et al. A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins. Scientific reports. 2017;7:39805. Epub 2017/01/12. doi: 10.1038/srep39805 28074920

42. Salinas CN, Anseth KS. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. Journal of tissue engineering and regenerative medicine. 2008;2(5):296–304. Epub 2008/05/31. doi: 10.1002/term.95 18512265.

43. Schiller HB, Hermann MR, Polleux J, Vignaud T, Zanivan S, Friedel CC, et al. beta1- and alphav-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments. Nature cell biology. 2013;15(6):625–36. Epub 2013/05/28. doi: 10.1038/ncb2747 23708002.

44. Bharadwaj M, Strohmeyer N, Colo GP, Helenius J, Beerenwinkel N, Schiller HB, et al. alphaV-class integrins exert dual roles on alpha5beta1 integrins to strengthen adhesion to fibronectin. Nature communications. 2017;8:14348. Epub 2017/01/28. doi: 10.1038/ncomms14348 28128308

45. Parizi M, Howard EW, Tomasek JJ. Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Experimental cell research. 2000;254(2):210–20. Epub 2000/01/21. doi: 10.1006/excr.1999.4754 10640419.

46. Tomasek JJ, Vaughan MB, Kropp BP, Gabbiani G, Martin MD, Haaksma CJ, et al. Contraction of myofibroblasts in granulation tissue is dependent on Rho/Rho kinase/myosin light chain phosphatase activity. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2006;14(3):313–20. Epub 2006/07/01. doi: 10.1111/j.1743-6109.2006.00126.x 16808810.

Článek vyšel v časopise


2019 Číslo 10